| Nombre del producto |
Cefoperazone sodium |
| Nombre en inglés |
Cefoperazone sodium; Cefoperazone Sodium salt; (6r-(6alpha,7beta(r*)))-7-(((((4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl)amino)(4-hydroxyphenyl)acetyl)amino)-3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid sodium salt; sodium (6R,7R)-7-{[(2R)-2-{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}-2-(4-hydroxyphenyl)acetyl]amino}-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate |
| Fórmula molecular |
C25H26N9NaO8S2 |
| Peso Molecular |
667.6492 |
| InChI |
InChI=1/C25H27N9O8S2.Na/c1-3-32-8-9-33(21(39)20(32)38)24(42)27-15(12-4-6-14(35)7-5-12)18(36)26-16-19(37)34-17(23(40)41)13(10-43-22(16)34)11-44-25-28-29-30-31(25)2;/h4-7,15-16,22,35H,3,8-11H2,1-2H3,(H,26,36)(H,27,42)(H,40,41);/q;+1/p-1/t15-,16-,22-;/m1./s1 |
| Número de registro CAS |
62893-20-3 |
| EINECS |
263-751-5 |
| Estructura Molecular |
|
| Símbolos de Peligro |
 Xn:Harmful;
|
| Códigos de Riesgos |
R42/43:;
|
| Descripción de Seguridad |
S22:;
S36/37:;
|
|
